About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalBiotech
Clinical Trials (30)
View allTotal Trials
30
As Lead Sponsor
28
As Collaborator
2
Total Enrollment
968
By Phase
PHASE1: 8PHASE1/PHASE2: 10PHASE2: 7
By Status
COMPLETED: 19TERMINATED: 4ENROLLING_BY_INVITATION: 3ACTIVE_NOT_RECRUITING: 3RECRUITING: 1
Clinical Trials Pipeline30 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
Today
Hover over trial bars to see details
Recent Trials
NCT06980948Lead Sponsor
Safety and Tolerability Study of ST-503 for Small Fiber Neuropathy-associated Refractory Pain
PHASE1Recruiting
27 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2028
NCT05987527Lead Sponsor
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)
N/AEnrolling by invitation
11 participants
Started: Aug 15, 2023 · Completed: Jun 11, 2039
NCT05145062Lead Sponsor
Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.
N/AEnrolling by invitation
12 participants
Started: Dec 21, 2021 · Completed: Jul 14, 2038
NCT05039866Lead Sponsor
Long-Term Follow-up of Subjects Who Were Treated With ST-920
N/AEnrolling by invitation
48 participants
Started: Aug 16, 2021 · Completed: Mar 31, 2039
NCT04817774Lead Sponsor
Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients
PHASE1/PHASE2Active, not recruiting
26 participants
Started: Mar 17, 2021 · Completed: Oct 29, 2025
Locations (1)
Headquarters
Richmond, CA, United States
Map
Loading map...